Nathan J. Dowden, COO: Entrada Therapeutics TRDA Sell · Filed 23/06/22

Trade details

Type: Insider sale
Amount: $132,741.9
Shares · price: 8,885 sh · $14.94 a share
Held after: 49,570 sh
Stock: Entrada Therapeutics TRDA
Person: Nathan J. DowdenCOO
Trade date: 23/06/20
Filed: 23/06/22
Days to filing: 2 days

Sold 15.2% of holdings

Share of holding sold: 15.2%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/21~23/07/20

Nathan J. Dowden's recent trades

Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$230K
15,000 sh
$230K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$217.5K
15,000 sh
$217.5K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$155.2K
11,894 sh
$155.2K
Filed 03/11
Traded 03/10
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$40.6K
3,116 sh
$40.6K
Filed 03/11
Traded 03/09
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$188.8K
15,010 sh
$188.8K
Filed 03/09
Traded 03/09